Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders
Status:
Completed
Trial end date:
2021-09-10
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled trial of choline supplementation in
children with Fetal Alcohol Spectrum Disorders (FASD). The primary outcome measures are
cognitive measures.
Phase:
Phase 2
Details
Lead Sponsor:
University of Minnesota University of Minnesota - Clinical and Translational Science Institute
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)